+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hyperhidrosis Treatment Market by Treatment Type, Distribution Channel, Anatomical Site, Condition Type, Treatment Setting - Global Forecast to 2030- Product Image
Hyperhidrosis Treatment Market by Treatment Type, Distribution Channel, Anatomical Site, Condition Type, Treatment Setting - Global Forecast to 2030- Product Image
Sale

Hyperhidrosis Treatment Market by Treatment Type, Distribution Channel, Anatomical Site, Condition Type, Treatment Setting - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715634
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hyperhidrosis treatment market is experiencing a pivotal transformation, with new therapies and accelerated collaboration shaping a landscape focused on improved clinical results and patient quality of life. Stakeholders face a fast-evolving environment driven by innovation, regulatory shifts, and the need for cost-effective, accessible solutions.

Market Snapshot: Hyperhidrosis Treatment Market Growth and Opportunity

The hyperhidrosis treatment market’s momentum is underscored by escalating demand for minimally invasive options, robust manufacturer innovation, and a global shift towards patient-centered care. The market grew from USD 647.88 million in 2024 to USD 694.14 million in 2025. It is projected to advance at a CAGR of 7.01%, with market value reaching USD 973.01 million by 2030. This growth trajectory signals rising recognition among patients, clinicians, and payers of the need for effective management of excessive sweating. The primary keyword, hyperhidrosis treatment market, anchors this snapshot, reflecting a sector positioned for significant transformation and investment.

Scope & Segmentation

  • Treatment Types: Injectable treatments (including Botulinum Toxin Types A and B), medical devices such as iontophoresis and microwave thermolysis systems, oral medications (anticholinergics, beta blockers), surgical interventions, and topical agents like aluminum chloride hexahydrate and glycopyrronium tosylate define the clinical solution range.
  • Distribution Channels: E-commerce platforms, over-the-counter (OTC) venues such as online and retail pharmacies, as well as prescription-only routes through dermatology clinics and hospitals, structure product availability and accessibility.
  • Anatomical Sites: Key focus areas are face, feet, palms, and underarm, each presenting unique clinical and commercial considerations.
  • Condition Types: Market segmentation distinguishes between primary hyperhidrosis and secondary cases associated with other health conditions.
  • Treatment Settings: Choices span general and specialized clinics, home-based care options, and hospital-based (inpatient and outpatient) programs.
  • Regions Covered: The report analyzes the Americas (highlighting the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with countries including the United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (spanning China, India, Japan, Australia, and more), capturing regional dynamics and growth opportunities.
  • Leading Technologies: The landscape is shaped by innovations in device integration, peptide-based topicals, advanced botulinum toxin products, and telemedicine-enabling digital health solutions.
  • Key Companies: Strategic analysis covers prominent manufacturers and pharmaceutical firms including AbbVie Inc., Bausch Health Companies Inc., Ipsen S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Hologic, Inc., Eli Lilly and Company, Evolus, Inc., Revance Therapeutics, Inc., and Dermira, Inc.

Key Takeaways for Decision-Makers

  • Innovation is driven by combination therapies that merge pharmacological and device-based approaches, offering broader therapeutic options and improved patient management.
  • At-home care solutions and digital health integration, such as remote monitoring and telemedicine, are expanding access and adherence while reducing stigma.
  • Strategic collaborations between patient advocacy groups, manufacturers, and regulatory agencies are influencing speed to market and shaping evidence requirements for new treatments.
  • Careful attention to reimbursement frameworks is essential as insurers adapt to novel technologies and real-world cost-benefit analyses.
  • Regional differences in patient populations, reimbursement structures, and cultural expectations necessitate tailored commercial strategies for optimal market entry and sustained leadership.

Tariff Impact on the Hyperhidrosis Treatment Market

Recent tariff implementations in the United States have introduced new cost pressures for both device and pharmaceutical manufacturers, impacting sourcing, logistics, and pricing practices across the supply chain. Companies have responded by exploring alternative manufacturing locations, renegotiating freight contracts, and considering tariff-exempt regions for assembly or contract production. Insurers and healthcare providers are actively seeking ways to absorb or offset these increased costs, with ongoing adjustments to reimbursement and procurement policies. Strategic realignment for procurement and cost management now constitutes a critical priority for market participants navigating evolving tariff landscapes.

Methodology & Data Sources

This report combines qualitative insights from interviews with key opinion leaders—spanning dermatology, neurology, endocrinology, and hospital management—with comprehensive secondary research across peer-reviewed publications, regulatory filings, patent records, and industry reports. Cross-validated data triangulation and structured segmentation frameworks ensure robust, accurate, and unbiased intelligence.

Why This Report Matters

  • Provides executive-level, actionable insights for evaluating growth opportunities, guiding product development, and optimizing market entry strategies across all major regions.
  • Equips senior leaders with the context needed to anticipate regulatory and reimbursement shifts, enabling agile adaptation to market forces and cost variability.
  • Supports informed decision-making on investment priorities, supply chain resilience, and partnership opportunities in a rapidly evolving treatment space.

Conclusion

The hyperhidrosis treatment market presents compelling opportunities for companies prepared to address patient needs with innovative, accessible solutions. Proactive adaptation and evidence-backed strategy will secure long-term value and leadership for organizations in this advancing sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hyperhidrosis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Injectable Treatments
8.2.1. Botulinum Toxin Type a
8.2.2. Botulinum Toxin Type B
8.3. Medical Devices
8.3.1. Iontophoresis Devices
8.3.2. Microwave Thermolysis Devices
8.4. Oral Medications
8.4.1. Anticholinergics
8.4.2. Beta Blockers
8.5. Surgical Treatments
8.6. Topical Agents
8.6.1. Aluminum Chloride Hexahydrate
8.6.2. Glycopyrronium Tosylate
9. Hyperhidrosis Treatment Market, by Distribution Channel
9.1. Introduction
9.2. E Commerce
9.3. OTC
9.3.1. Online Pharmacies
9.3.2. Retail Pharmacies
9.4. Prescription
9.4.1. Dermatology Clinics
9.4.2. Hospitals
10. Hyperhidrosis Treatment Market, by Anatomical Site
10.1. Introduction
10.2. Face
10.3. Feet
10.4. Palms
10.5. Underarm
11. Hyperhidrosis Treatment Market, by Condition Type
11.1. Introduction
11.2. Primary Hyperhidrosis
11.3. Secondary Hyperhidrosis
12. Hyperhidrosis Treatment Market, by Treatment Setting
12.1. Introduction
12.2. Clinic
12.2.1. General Clinics
12.2.2. Specialized Clinics
12.3. Home
12.4. Hospital
12.4.1. Inpatient
12.4.2. Outpatient
13. Americas Hyperhidrosis Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hyperhidrosis Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hyperhidrosis Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Bausch Health Companies Inc.
16.3.3. Ipsen S.A.
16.3.4. Galderma S.A.
16.3.5. Merz Pharma GmbH & Co. KGaA
16.3.6. Hologic, Inc.
16.3.7. Eli Lilly and Company
16.3.8. Evolus, Inc.
16.3.9. Revance Therapeutics, Inc.
16.3.10. Dermira, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HYPERHIDROSIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. HYPERHIDROSIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. HYPERHIDROSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HYPERHIDROSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HYPERHIDROSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HYPERHIDROSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY IONTOPHORESIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MICROWAVE THERMOLYSIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ALUMINUM CHLORIDE HEXAHYDRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY GLYCOPYRRONIUM TOSYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY FACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY FEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PALMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY UNDERARM, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRIMARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SECONDARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 82. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 83. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 84. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 87. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 88. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 89. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 91. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 92. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 93. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 96. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 100. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 104. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 105. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 159. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 163. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 164. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 166. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 167. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 168. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 169. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 170. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 171. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 172. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 179. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 181. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 182. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 183. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 184. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 198. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 199. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 200. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 201. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 202. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 203. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 205. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 206. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 207. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 208. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 209. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 210. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 211. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 213. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 214. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 215. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 216. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 218. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 219. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 220. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 221. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 222. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 223. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 263. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 265. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 266. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 267. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 268. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 270. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 271. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 272. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 273. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 274. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 275. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 289. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 290. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 291. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 292. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 293. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 294. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 296. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 297. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 298. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 299. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 300. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 301. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 302. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 304. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 305. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 306. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 307. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 309. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 310. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 311. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 312. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 313. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 314. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 315. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 316. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY INJECTABLE TREATMENTS, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY ANATOMICAL SITE, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY CONDITION TYPE, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN HYPERHIDROSI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hyperhidrosis Treatment market report include:
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Ipsen S.A.
  • Galderma S.A.
  • Merz Pharma GmbH & Co. KGaA
  • Hologic, Inc.
  • Eli Lilly and Company
  • Evolus, Inc.
  • Revance Therapeutics, Inc.
  • Dermira, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 694.14 Million
Forecasted Market Value ( USD ) by 2030 $ 973.01 Million
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Palmar Hyperhidrosis Epidemiology Forecast 2025-2034 - Product Image

Palmar Hyperhidrosis Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Hyperhidrosis Treatment Market Report 2025 - Product Image

Hyperhidrosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Hyperhidrosis Treatment - Global Strategic Business Report - Product Image

Hyperhidrosis Treatment - Global Strategic Business Report

  • Report
  • 480 Pages
  • Global
From
Hyperhidrosis - Pipeline Insight, 2025 - Product Image

Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Axillary Hyperhidrosis - Pipeline Insight, 2025 - Product Image

Axillary Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • 40 Pages
  • Global
From

About the Hyperhidrosis Drug Market

Hyperhidrosis is a medical condition characterized by excessive sweating. It is a common disorder that affects millions of people worldwide. Endocrinology is the branch of medicine that deals with the diagnosis and treatment of disorders related to hormones and the endocrine system. Hyperhidrosis is a disorder that is often treated by endocrinologists. The hyperhidrosis drug market is a rapidly growing segment of the endocrinology market. It is driven by the increasing prevalence of hyperhidrosis, the availability of new treatments, and the growing awareness of the condition. The market is expected to grow at a steady rate in the coming years due to the increasing demand for effective treatments. Some of the major companies in the hyperhidrosis drug market include GlaxoSmithKline, Merck & Co., Pfizer, Johnson & Johnson, and Novartis. These companies are actively involved in the development and marketing of drugs for the treatment of hyperhidrosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.